AMGN Competitors
Amgen Inc.
$427.24
-$5.25(-1.21%)
65
Overall
80
Value
63
Tech
52
Quality
Market Cap
$233.82B
Volume
586.62K
52W Range
$288.00 - $447.03
Target Price
$403.61
AMGN competitors: BMY, PFE, GSK, GILD, ABBV. Amgen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMGN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $59.75 | $122.05B | $6.80 | 4.22% | 60 |
| PFE Pfizer Inc. | $29.58 | $168.60B | $2.96 | 5.81% | 70 |
| GSK GSK plc | $49.51 | $100.32B | $4.78 | 3.67% | 46 |
| GILD Gilead Sciences, Inc. | $156.19 | $193.67B | $-0.47 | 2.08% | 76 |
| ABBV AbbVie Inc. | $285.42 | $504.37B | $13.94 | 1.82% | 67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $427.24 | -1.2% | 586.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |